For Type 1 Diabetes, Teplizumab (Tzield) Preserves Beta Cell Function and Shows Significant Other Benefits

The preservation of insulin-producing beta cells is just one of the benefits of teplizumab, also known as Tzield, a phase 3 trial shows.

Related Keywords

Kevan Herold ,Teplizumab Tzield ,Drug Administration ,New England Journal ,Medicineon October ,Long Professor ,Pediatric Quality ,Life Inventory Diabetes ,Family Module ,Hypoglycemia Fear Scale ,Diabetes Treatment Satisfaction ,